Skip to main content

We’re an independent group, solely focused on innovating, developing, producing, and marketing veterinary drugs and non-medicinal products globally.

In 2020, our group registered a sales revenue of €427.5m. This was from 24 countries with equal amounts coming from livestock and pets. And it was all thanks to our established network of 100 partner distributors.

Since our creation in 1933, Vetoquinol has combined innovation and geographical diversification. The strengthening of our product portfolio – and the acquisition of Bioniche Animal Health in 2014 – has ensured growth for our group. Today, Vetoquinol employs more than 2,400 people.

Vetoquinol’s key figures for 2020

2020 turnover: € 427.5 million
Essential products turnover: € 220.6 million
Breakdown of group turnover by activity:

Pets (€ 256.7m) 60%
Livestock (170.7 M €) 40%



2020 key figures